KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbCellera Biologics (ABCL) Income from Continuing Operations (2020 - 2026)

AbCellera Biologics filings provide 7 years of Income from Continuing Operations readings, the most recent being 43165000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations rose 5.38% to 43165000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 143956000.0 through Mar 2026, up 14.24% year-over-year, with the annual reading at 146412000.0 for FY2025, 10.1% up from the prior year.
  • Income from Continuing Operations hit 43165000.0 in Q1 2026 for AbCellera Biologics, down from 8945000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 168573000.0 in Q1 2022 and bottomed at 57119000.0 in Q3 2025.
  • Average Income from Continuing Operations over 5 years is 20018411.76, with a median of 34727000.0 recorded in 2025.
  • The largest annual shift saw Income from Continuing Operations surged 224.53% in 2022 before it tumbled 349.93% in 2023.
  • AbCellera Biologics' Income from Continuing Operations stood at 29893000.0 in 2022, then crashed by 57.73% to 47150000.0 in 2023, then grew by 27.44% to 34210000.0 in 2024, then soared by 73.85% to 8945000.0 in 2025, then crashed by 382.56% to 43165000.0 in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Income from Continuing Operations are 43165000.0 (Q1 2026), 8945000.0 (Q4 2025), and 57119000.0 (Q3 2025).